These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37841777)

  • 21. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
    Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
    Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
    Gao J; Song L; Li D; Peng L; Ding H
    Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing malignant pleural effusion using clinical and analytical parameters.
    Pan Y; Bai W; Chen J; Mao Y; Qian X; Xu K; Tang S; Zhang J; Chen C; Chen J; Hu X
    J Clin Lab Anal; 2019 Feb; 33(2):e22689. PubMed ID: 30390322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
    Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
    Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
    Li JN; Feng ZE; Wang L; Wang YX; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
    Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
    BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
    Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
    BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary investigation of the clinical value of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in pericardial fluid in diagnosing malignant and tuberculous pericardial effusion.
    Liu J; Zeng Y; Ma W; Chen S; Zheng Y; Ye S; Lan L; Weig HJ; Liu Q
    Cardiology; 2010; 116(1):37-41. PubMed ID: 20424452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
    Wang T; Wang N; Zhang L; Liu Y; Thakur A
    Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
    Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
    BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
    Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of malignant-associated pleural effusion on endothelial viability, motility and angiogenesis in lung cancer.
    Changchien CY; Chen Y; Chang HH; Chang SY; Tsai WC; Tsai HC; Wang CY; Lee HS; Tsai CL
    Cancer Sci; 2020 Oct; 111(10):3747-3758. PubMed ID: 32706142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
    Bao Q; Xu Y; Ding M; Chen P
    Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
    Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
    Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine: new tumor marker in pleural fluid.
    Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
    Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy.
    Xiang Z; Deng X; He W; Yang Q; Ni L; Dehghan Shasaltaneh M; Maghsoudloo M; Yang G; Wu J; Imani S; Wen Q
    Ann Med; 2022 Dec; 54(1):1357-1371. PubMed ID: 35543207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically occult primary fallopian tube carcinoma presenting as a malignant pleural effusion.
    Hiensch R; Meinhof K; Leytin A; Hagopian G; Szemraj E; Epelbaum O
    Clin Respir J; 2017 Nov; 11(6):1086-1090. PubMed ID: 26646473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kurokawa T; Miyamoto M; Kato K; Cho Y; Kawarada Y; Hida Y; Shinohara T; Itoh T; Okushiba S; Kondo S; Katoh H
    Br J Cancer; 2003 Sep; 89(6):1042-7. PubMed ID: 12966423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma.
    Budak A; Yanarateş A; Budak E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
    Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
    Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.